insurer coverage glp-1 news today A Re/Insurance View Of GLP-1s Some US employers to drop

In this combined analysis, we observe that the degree of BMI loss depends strongly on sex, drug type, time on treatment and drug dosage, consistent with previous reports 11 , and has a relatively weak dependence on pre-treatment BMI (with higher starting BMI associated with greater BMI loss)

The goal of nonsurgical therapy should be a scientifically feasible, safe approach to prevent the progression of, or reduce, deformity and improve sexual function

As research continues to evolve, therapies targeting cellular metabolism may become increasingly important tools in preventive health and longevity strategies.

J Chem Neuroanat 2023;127:102207